Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
three-generation reproductive toxicity
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study performed to GLP and guideline

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
EU Method B.35 (Two-Generation Reproduction Toxicity Test)
GLP compliance:
yes

Test material

Constituent 1
Reference substance name:
Sodium salt of cyanuric acid (s-triazinetriol)
IUPAC Name:
Sodium salt of cyanuric acid (s-triazinetriol)
Details on test material:
- Name of test material (as cited in study report): Sodium salt of cyanuric acid (s-triazinetriol)
- Substance type: powder
- Analytical purity: Equivalent to 77.05% cyanuric acid
- Lot/batch No.: 1785021-1

Test animals

Species:
rat
Strain:
other: Charles River CD
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Portage, Michigan, USA.
- Housing: Wire mesh cages
- Diet : ad libitum
- Water: ad libitum
- Acclimation period: 15 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-25
- Humidity (%): 50 ± 15%
- Air changes (per hr): 10-11
- Photoperiod (hrs dark / hrs light): 12/12


Administration / exposure

Route of administration:
oral: drinking water
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:
A factor of 1.2979 was utilized in dosage calculations to adjust for the base composition (77.05%) of cyanuric acid in the test article. The appropriate amounts of the sodium salt of cyanuric acid (s-triazinetriol) were dissolved in tap water, utilizing a motor driven propeller, to permit administration at concentrations of 400, 1200 and 5375 ppm of s-triazinetriol. Each test solution was adjusted to a pH of 7.4 at approximately 25°C using glacial acetic acid or a 1% sodium hydroxide solution. The amounts of acid or base used were recorded. Fresh test solutions were prepared twice each week.

Details on mating procedure:
- M/F ratio per cage: 1 male per two females
- Length of cohabitation: 14 days
- Proof of pregnancy: vaginal plug and or vaginal smear referred to as day 0 of gestation
- After 7 days of unsuccessful pairing replacement of first male by another male with proven fertility.
- The F0 and F1 parents were mated twice to produce 'a' and 'b' offspring, the F2 parents were mated once to produce the F3 offspring
Duration of treatment / exposure:
Exposure period: Treatment was initiated at 36 days of age to the F0 generation and at 21 days of age to F1 and F2 parents of both sexes. Test solution was administered until termination of each generation
Premating exposure period (males): F0: minimum 100 days (14 weeks) of treatment, F1 and F2: minimum 120 days of treatment.
Premating exposure period (females): F0: minimum 100 days (14 weeks) of treatment, F1 and F2: minimum 120 days of treatment.
Frequency of treatment:
Ad libitum
Doses / concentrations
Remarks:
Doses / Concentrations:
400, 1200 and 5375 ppm (males F0 ~35, ~100, ~470 mg/kg bw/d; F1 ~36, ~110, ~500 mg/kg bw/d; F2 ~40, ~110, ~485 mg/kg bw/d; females, F0 ~64, ~185, ~950 mg/kg bw/d; F1 ~63, ~190, ~910 mg/kg bw/d; F2 ~65, ~195, ~970 mg/kg bw/d)
Basis:

No. of animals per sex per dose:
12 males 24 females / dose level
Control animals:
other: Vehicle (tap water), Sodium control (sodium hippurate 8056 ppm)
Details on study design:
The concentration of sodium hippurate was selected to permit the administration of an equal concentration of ionic sodium as that contributed by the test article at the high dose level.

Examinations

Parental animals: Observations and examinations:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Twice each day
- Cage side observation included signs of overt toxicity, changes in general appearance, behaviour and mortality.


DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Weekly


BODY WEIGHT: Yes
- Time schedule for examinations: Weekly


FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes


WATER CONSUMPTION: Yes
- Time schedule for examinations: Weekly except during mating mating periods


Litter observations:

PARAMETERS EXAMINED
The following parameters were examined in F1 / F2 / F3 offspring:
The number and sex of pups, stillbirths, live births, presence of gross anomalies, weight gain, physical or behavioural abnormalities, pup survival through weaning, pup weight at birth and specified intervals during lactation.



Postmortem examinations (parental animals):
SACRIFICE
- Male animals: All surviving animals
- Maternal animals: All surviving animals


HISTOPATHOLOGY:
Gonads and gross lesions

ORGAN WEIGHTS:
Adrenal glands, brain, heart, liver, ovaries (2), spleen, testes, epididymides (2) and thyroid.
Postmortem examinations (offspring):
SACRIFICE
- All F1b and F2b pups not selected as parents. All F3 pups retained after weaning.



ORGAN WEIGHTS:
Adrenal glands, brain, heart, liver, ovaries (2), spleen, testes, epididymides (2) and thyroid.

HISTOPATHOLOGY:
F1b and F2b pups (5/sex from control, high dose and sodium control) and F3 (5/sex/group) as follows: adrenals, aorta, bone (tibia with marrow), brain (longitudinal section), colon, duodenum, esophagus, eyes, heart, ileum, jejunum, kidney, liver, lungs, lymph node (mesenteric), mammary gland, ovaries, pancreas, pituitary, peripheral nerve, prostate, salivary gland, seminal vesicles, skeletal muscle, skin (with cervical lymph node), spleen, stomach, testes (with epididymis), thymus, thyroid (with parathyroids), thrachaea, urinary bladder, uterus, cervix, all the gross lesions, tissue masses, spinal cord and ureter
Statistics:
Analysis compared the treated groups to the control and sodium control groups and the control and sodium control groups were compared to each other. The parental body weights by sex were analyzed by one-way analysis of variance, Bartletts test for homogeneity of variances and the appropriate t-test (for equal or unequal variances). In all generations analyses were conducted at one week prior to the first mating, one week prior to the second mating and at termination of the generation. In addition, analyses were conducted at initiation of the F1 and F2 generations. Male and female indices were compared using the Chi-square test criterion with Yates' correction for 2 x 2 contingency tables and/or Fishers exact probability test. The proportion of live pups at birth per total number born and the survival indices at lactation days 4, 7, 14 and 21 were compared by the Mann-Whitney U-test. The mean numbers of liveborn pups per litter and mean body weights of pups were analyzed by one-way analysis of variance, Bartletts test for homogeneity of variances and the appropriate t-test (for equal or unequal variances). Organ weights by sex were analyzed by one-way analysis of variance, Bartlett's test for homogeneity of variances, and the appropriate t-test (for equal or unequal variances).

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
no effects observed
Mortality:
mortality observed, non-treatment-related
Description (incidence):
2 control, 2 high-dose and 1 sodium control males failed to survive to scheduled sacrifice. One male control and one male in the high dose groups were sacrificed in extremis. All deaths and sacrifices occurred between weeks 11 and 34. Surviving animals showed no biologically significant effects.
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Description (incidence and severity):
an increase in high dose females was observed
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
not examined
Other effects:
no effects observed

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
not examined
Reproductive performance:
no effects observed

Details on results (P0)

MALES:
Appearance, behaviour and mortality: 2 control, 2 high-dose and 1 sodium control males failed to survive to scheduled sacrifice. One male control and one male in the high dose groups were sacrificed in extremis. All deaths and sacrifices occurred between weeks 11 and 34. Surviving animals showed no biologically significant effects.
Body weights: no biologically significant effects were observed.
Food consumption: no effects.
Water consumption: no treatment effect was presumed.

FEMALES:
Appearance, behaviour and mortality: no effects.
Body weights: no biologically significant effects were observed.
Food consumption: no effects.
Water consumption: an increase in high dose females was observed.

Effect levels (P0)

open allclose all
Key result
Dose descriptor:
NOAEL
Effect level:
ca. 470 mg/kg bw/day
Based on:
test mat.
Sex:
male
Basis for effect level:
mortality
reproductive performance
Key result
Dose descriptor:
NOAEL
Effect level:
ca. 950 mg/kg bw/day
Based on:
test mat.
Sex:
female
Basis for effect level:
mortality
reproductive performance

Results: P1 (second parental generation)

General toxicity (P1)

Clinical signs:
no effects observed
Mortality:
mortality observed, non-treatment-related
Description (incidence):
one male in each of the high dose and sodium control groups failed to survive to scheduled sacrifice. Surviving animals showed no biologically significant effects.
one female from each of the control, low and mid dose and sodium control groups between week 38 and 63 exhibited no overt clinical signs prior to death. One control group female was sacrificed in extremis during study week 61. Surviving animals showed no biologically significant effects.
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
a slight to moderate increase in the high dose and sodium control groups were observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Description (incidence and severity):
an increase in high dose and sodium control females was observed
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
not examined
Histopathological findings: neoplastic:
not examined
Other effects:
no effects observed
Details on results:
1.1.1 F1 males Appearance, behaviour and mortality: one male in each of the high dose and sodium control groups failed to survive to scheduled sacrifice. Surviving animals showed no biologically significant effects.
Body weights: a slight to moderate increase in the high dose and sodium control groups were observed.
Food consumption: no effects.
Water consumption: no treatment effect was presumed.
1.1.2 F1 females Appearance, behaviour and mortality: one female from each of the control, low and mid dose and sodium control groups between week 38 and 63 exhibited no overt clinical signs prior to death. One control group female was sacrificed in extremis during study week 61. Surviving animals showed no biologically significant effects.
Body weights: a slight to moderate increase in the high dose and sodium control groups were observed.
Food consumption: no effects.
Water consumption: an increase in high dose and sodium control females was observed.

Reproductive function / performance (P1)

Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
not examined
Reproductive performance:
no effects observed

Details on results (P1)

No significant fluctuations in reproductive or litter parameters. Fertility indices, gestation lengths, litter sizes, pup survival to weaning and pup weights at parturition and throughout lactation were comparable with controls.

Effect levels (P1)

open allclose all
Key result
Dose descriptor:
NOAEL
Effect level:
>= 500 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male
Basis for effect level:
mortality
Dose descriptor:
NOAEL
Effect level:
>= 910 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
female
Basis for effect level:
mortality

Results: F1 generation

General toxicity (F1)

Clinical signs:
no effects observed
Mortality / viability:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Description (incidence and severity):
an increase in high dose and sodium control females was observed
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Sexual maturation:
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings:
effects observed, treatment-related
Other effects:
no effects observed

Developmental neurotoxicity (F1)

Behaviour (functional findings):
not examined

Developmental immunotoxicity (F1)

Developmental immunotoxicity:
not examined

Details on results (F1)

F1 MALES:
Appearance, behaviour and mortality: one male in each of the high dose and sodium control groups failed to survive to scheduled sacrifice. Surviving animals showed no biologically significant effects.
Body weights: a slight to moderate increase in the high dose and sodium control groups were observed.
Food consumption: no effects.
Water consumption: no treatment effect was presumed.

F1 FEMALES:
Appearance, behaviour and mortality: one female from each of the control, low and mid dose and sodium control groups between week 38 and 63 exhibited no overt clinical signs prior to death. One control group female was sacrificed in extremis during study week 61. Surviving animals showed no biologically significant effects.
Body weights: a slight to moderate increase in the high dose and sodium control groups were observed.
Food consumption: no effects.
Water consumption: an increase in high dose and sodium control females was observed.

F2 MALES:
Appearance, behaviour and mortality: one 400 ppm male died during week 98. Two males in the 5375 ppm group died, one at week 83, one at week 100. Surviving animals showed no biologically significant effects.
Body weights: no biologically significant effects were observed. An increased incidence of calculi in the urinary bladder in the 5375 ppm males was related to the test article.
Food consumption: no effects.
Water consumption: no treatment effect was presumed.

F2 FEMALES:
Appearance, behaviour and mortality: one 400 ppm female died immediately prior to initiation of the generation. One female died in the sodium control group on day 20. Surviving animals showed no biologically significant effects.
Body weights: a slight to moderate increase in the mid dose group was observed.
Food consumption: no effects.
Water consumption: an increase in high dose and sodium control females was observed.

Effect levels (F1)

open allclose all
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
ca. 500 mg/kg bw/day
Based on:
test mat.
Sex:
male
Basis for effect level:
mortality
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
ca. 910 mg/kg bw/day
Based on:
test mat.
Sex:
female
Basis for effect level:
mortality

Results: F2 generation

General toxicity (F2)

Clinical signs:
effects observed, non-treatment-related
Description (incidence and severity):
one 400 ppm male died during week 98. Two males in the 5375 ppm group died, one at week 83, one at week 100. Surviving animals showed no biologically significant effects.
one 400 ppm female died immediately prior to initiation of the generation. One female died in the sodium control group on day 20. Surviving animals showed no biologically significant effects.
Mortality / viability:
mortality observed, non-treatment-related
Description (incidence and severity):
one 400 ppm male died during week 98. Two males in the 5375 ppm group died, one at week 83, one at week 100. Surviving animals showed no biologically significant effects.
one 400 ppm female died immediately prior to initiation of the generation. One female died in the sodium control group on day 20. Surviving animals showed no biologically significant effects.
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
a slight to moderate increase in the mid dose group females was observed.
An increased incidence of calculi in the urinary bladder in the 5375 ppm males was related to the test article.
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Description (incidence and severity):
an increase in high dose and sodium control females was observed
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Sexual maturation:
no effects observed
Organ weight findings including organ / body weight ratios:
no effects observed
Gross pathological findings:
no effects observed
Histopathological findings:
no effects observed

Developmental neurotoxicity (F2)

Behaviour (functional findings):
not examined

Developmental immunotoxicity (F2)

Developmental immunotoxicity:
not examined

Details on results (F2)

1.1.1 F2 males Appearance, behaviour and mortality: one 400 ppm male died during week 98. Two males in the 5375 ppm group died, one at week 83, one at week 100. Surviving animals showed no biologically significant effects.
Body weights: no biologically significant effects were observed. An increased incidence of calculi in the urinary bladder in the 5375 ppm males was related to the test article.
Food consumption: no effects.
Water consumption: no treatment effect was presumed.
1.1.2 F2 females Appearance, behaviour and mortality: one 400 ppm female died immediately prior to initiation of the generation. One female died in the sodium control group on day 20. Surviving animals showed no biologically significant effects.
Body weights: a slight to moderate increase in the mid dose group was observed.
Food consumption: no effects.
Water consumption: an increase in high dose and sodium control females was observed.

Effect levels (F2)

open allclose all
Key result
Dose descriptor:
NOAEL
Generation:
F2
Effect level:
ca. 190 mg/kg bw/day
Based on:
test mat.
Sex:
male
Basis for effect level:
mortality
Dose descriptor:
NOAEL
Generation:
F2
Effect level:
ca. 970 mg/kg bw/day
Based on:
test mat.
Sex:
female
Basis for effect level:
mortality

Overall reproductive toxicity

Key result
Reproductive effects observed:
no
Lowest effective dose / conc.:
470 mg/kg bw/day (nominal)
Treatment related:
no

Any other information on results incl. tables

S-triazinetriol had no significant effect on survival, appearance or behaviour including nesting and nursing behaviour.  No cross generational trends indicative of a test article effect on parental body weight was noted, nor was food consumption affected.  A consistent cross generational trend of increased water consumption was noted in high dose females, which in the F1 and F2 generations was accompanied by a concurrent increase in sodium control female values, although the role of increased sodium intake versus that of cyanuric acid is unclear. 

The survival, general appearance, behaviour, mean body weights and food and water consumption of retained F3 pups were uniform in all study groups.  Treatment with s-triazinetriol at concentrations of 5375 ppm or less did not induce significant fluctuations in reproductive or litter parameters.  Fertility indices, gestation length, litter size, pup survival to weaning and pup weights at parturition and throughout lactation of treated groups, including the sodium control were comparable to those of the controls.  An increased incidence of calculi in the urinary bladder in 5375 ppm F2 males was related to the test article.  The findings with respect to female water consumption in the high-dose group and the post-mortem urinary bladder findings in the high-dose F2 males had no biologically detrimental effect on the reproductive potential of the parents or on the growth and development of the offspring

Table A6_8_2(1)-1.  Table for Reproductive Toxicity Study

Parameter

 

Control

0 ppm

Low Dose

400 ppm

Medium Dose

1200 ppm

High Dose

5375 ppm

Sodium Control

Genera­tion

m

f

m

f

m

f

m

f

m

f

Mortality

incidence

F1

0

2

0

1

0

1

1

0

1

1

 

 

F2

0

0

1

1

0

0

2

0

0

1

 

 

F3

0

0

0

0

0

0

1

0

0

1

Clinical Observations

hydronephrosis

Incidence

P

3

0

0

2

0

3

5

4

2

0

 

 

F1

0

0

1

5

1

2

3

3

2

3

 

 

F2

0

0

1

1

0

1

0

3

1

3

Reproductive Performance

 

 

 

 

 

 

 

 

 

 

 

 

Mating index (%)

(%)

F1a

 

95.8

 

91.7

 

95.8

 

91.7

 

100

 

(%)

F1b

 

95.0

 

95.2

 

81.0

 

100

 

95.5

 

(%)

F2a

 

78.3

 

60.9

 

79.2

 

70.8

 

79.2

 

(%)

F2b

 

77.3

 

65.2

 

82.6

 

91.7

 

100

 

(%)

F3

 

95.8

 

68.2

 

87.5

 

91.7

 

100

Fertility index

 

F1a

90.9

83.3

100

87.5

91.7

87.5

91.7

83.3

90.9

95.8

 

 

F1b

100

95.0

100

90.5

91.7

81.0

81.8

95.0

100

81.8

 

 

F2a

83.3

56.5

75.0

60.9

66.7

54.2

100

66.7

90.9

75.0

 

 

F2b

50.0

40.9

66.7

52.2

91.7

69.6

100*

70.8

90.9

56.5

 

 

F3

100

95.8

58.3

50.0**

100

87.5

90.9

83.3

100

83.3

Gestation index

(%)

F1a

 

83.3

 

87.5

 

87.5

 

83.3

 

95.8

 

(%)

F1b

 

95.0

 

90.5

 

81.0

 

95.0

 

81.8

 

(%)

F2a

 

56.5

 

60.9

 

54.2

 

66.7

 

75.0

 

(%)

F2b

 

40.9

 

52.2

 

69.6

 

70.8

 

56.5

 

(%)

F3

 

95.8

 

68.2

 

87.5

 

91.7

 

100

Litter size

Mean

F2a

9.6

 

9.8

 

8.7

 

10

 

9.1

 

 

Mean

F2b

10

 

9.3

 

8.7

 

9.1

 

9.1

 

 

Mean

F3

9

 

9.8

 

9.7

 

9.9

 

8.8

 

Pup weight#Mean

Lactation day 0

F2a

6.1

 

6.2

 

6.4

 

6.1

 

6.2

 

 

Lactation day 0

F2b

6.0

 

6.4

 

6.3

 

6.1

 

6.5

 

 

Lactation day 0

F3

6.4

 

6.3

 

6.1

 

5.9

 

5.9

 

Sex ratio

Male/female

F2a

57 : 68

 

64 : 73

 

51 : 48

 

88 : 72

 

82 : 82

 

 

Male/female

F2b

41 : 49

 

57 : 54

 

71 : 68

 

74 : 71

 

55 : 63

 

 

Male/female

F3

113: 93

 

53 : 55

 

105 : 99

 

95 : 102

 

76 : 92

 

Survival index#

Lactation day 0

F1a

98.4

 

98.9

 

99.2

 

99.6

 

98.2

 

 

Lactation day 0

F1b

95.7

 

98.8

 

98.0

 

94.4

 

97.3

 

 

Lactation day 0

F2a

98.0

 

95.1

 

95.2

 

99.0

 

97.6

 

 

Lactation day 0

F2b

100

 

100

 

97.8

 

90.2

 

99.4

 

 

Lactation day 0

F3a

98.8

 

97.6

 

97.0

 

98.1

 

98.6

 

 

Lactation day 4

F1a

98.7

 

99.3

 

98.9

 

98.7

 

97.0

 

 

Lactation day 4

F1b

99.5

 

99.2

 

99.0

 

97.9

 

99.5

 

 

Lactation day 4

F2a

98.6

 

100

 

98.3

 

99.5

 

99.0

 

 

Lactation day 4

F2b

99.2

 

100

 

99.4

 

97.7

 

100

 

 

Lactation day 4

F3a

99.2

 

100

 

96.9

 

98.8

 

98.1

 

 

Lactation day 7

F1a

100

 

99.0

 

100

 

99.5

 

100

 

 

Lactation day 7

F1b

100

 

100

 

100

 

99.4

 

99.

 

 

Lactation day 7

F2a

100

 

100

 

98.1

 

100

 

99.4

 

 

Lactation day 7

F2b

100

 

100

 

100

 

100

 

100

 

 

Lactation day 7

F3a

99.5

 

100

 

100

 

99.5

 

96.5

 

 

Lactation day 14

F1a

100

 

100

 

99.5

 

100

 

99.5

 

 

Lactation day 14

F1b

100

 

100

 

100

 

100

 

100

 

 

Lactation day 14

F2a

100

 

100

 

100

 

100

 

100

 

 

Lactation day 14

F2b

100

 

100

 

99.3

 

100

 

100

 

 

Lactation day 14

F3a

100

 

100

 

100

 

100

 

99.4

 

 

Lactation day 21

F1a

99.5

 

100

 

100

 

100

 

100

 

 

Lactation day 21

F1b

100

 

100

 

100

 

100

 

100

 

 

Lactation day 21

F2a

100

 

100

 

99.0

 

100

 

95.9

 

 

Lactation day 21

F2b

100

 

100

 

100

 

100

 

100

 

 

Lactation day 21

F3a

100

 

100

 

99.5

 

100

 

100

 

* Significantly different from the control value (p < 0.05)

** Significantly different from the control value (p < 0.01)

#Does not distiguish between male and female.

Applicant's summary and conclusion

Conclusions:
No biologically detrimental effect on the reproductive potential of the parents or on the growth and development of the offspring.